Solifenacin succinate

CAS No. 242478-38-2

Solifenacin succinate ( Isoprenalinoe sulfate; YM-67905 )

Catalog No. M13700 CAS No. 242478-38-2

Solifenacin Succinate(YM905; Vesicare) is a muscarinic receptor antagonist.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 38 In Stock
50MG 42 In Stock
100MG 80 In Stock
200MG 109 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Solifenacin succinate
  • Note
    Research use only, not for human use.
  • Brief Description
    Solifenacin Succinate(YM905; Vesicare) is a muscarinic receptor antagonist.
  • Description
    Solifenacin Succinate(YM905; Vesicare) is a muscarinic receptor antagonist.
  • Synonyms
    Isoprenalinoe sulfate; YM-67905
  • Pathway
    Endocrinology/Hormones
  • Target
    AChR
  • Recptor
    mAChR
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    242478-38-2
  • Formula Weight
    480.56
  • Molecular Formula
    C23H26N2O2·C4H6O4
  • Purity
    >98%(HPLC)
  • Solubility
    Ethanol: 5 mg/mL (10.4 mM); Water: 96 mg/mL (199.77 mM); DMSO: 3 mg/mL (6.24 mM)
  • SMILES
    C1CN2CCC1[C@H](C2)OC(=O)N3CCC4=CC=CC=C4[C@@H]3C5=CC=CC=C5.C(CC(=O)O)C(=O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Sinha S, et al. Br J Pharmacol. 2010 Jul;160(5):1119-27.
molnova catalog
related products
  • Dextromethorphan HBr...

    Methyl analog of dextrorphan that shows high affinity binding to several regions of the brain, including the medullary cough center.

  • TAE-1

    TAE-1 is an inhibitor of amyloid-β fibril formation and aggregation. It inhibits cholinesterases AChE and BuChE with IC50 of 0.3 μM and 3.9 μM, respectively.

  • Theophylline

    Theophylline is a methylated xanthine derivative; competitive nonselective phosphodiesterase inhibitor and nonselective adenosine receptor antagonist.